One of the more notable successes of President Donald Trump’s first term was how the administration was able to develop ...

Scientists say HHS’s decision to stop investing in mRNA vaccine research is another sign of the growing politicization of ...

On Aug. 5, Robert F. Kennedy Jr. posted video to X announcing HHS was canceling mRNA vaccine research, confusing the Trump ...

Soligenix (NASDAQ: SNGX) , a late-stage biopharma company developing treatments for rare diseases, reported Q2 2025 results and recent milestones. Th ...

Trauma doesn't wait, and neither should treatment. Despite advancements in emergency medical services, 42% of hemorrhaging ...

Traws Pharma, Inc. ( NASDAQ: TRAW) Q2 2025 Earnings Conference Call August 14, 2025 8:30 AM ET Charles Parker - Interim Chief Financial Officer David Pauza - Corporate Participant Iain D. Dukes - ...

Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage trial, ...

Doctors and scientists who spoke to HuffPost are worried for a multitude of reasons and want you to know that this will ...

MDAI READ THE FULL MDAI RESEARCH REPORT Spectral AI, Inc. (NASDAQ:MDAI) reports second quarter earnings just weeks after ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

VANGUARD has selected five companies for up to $200,000 in non-dilutive funding contracts and 10 companies for the 2025 ...

Advancing novel programs for respiratory viruses that pose pandemic threats or risk of serious illness, including SARS CoV2 ...